S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

INVO Bioscience (INVO) Earnings Date, Estimates & Call Transcripts

$1.21
+0.06 (+5.22%)
(As of 03/1/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

INVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INVO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

INVO Earnings Date and Information

INVO Bioscience has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 15th, 2024 based off prior year's report dates.

INVO Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/15/2024
Estimated)
------- 
11/13/2023Q3 2023-($0.70)($0.70)($0.70)-$0.98 million
8/14/2023Q2 2023-($3.06)($3.06)($3.06)-$0.32 million
5/15/2023Q1 2023-($4.00)($4.00)($0.20)-$0.35 million
4/17/2023Q4 2022-($4.60)($4.60)($0.23)-$0.28 million
11/14/2022Q3 2022($2.40)($4.20)($1.80)($0.21)$0.23 million$0.24 million
8/15/2022Q2 2022($4.80)($4.60)+$0.20($0.23)$0.26 million$0.15 million
5/16/2022Q1 2022($5.00)($4.60)+$0.40($0.23)$0.97 million$0.16 million
11/15/2021Q3 2021($4.00)($4.80)($0.80)($0.24)$0.25 million$0.22 million    
8/15/2021Q2 2021($3.80)($3.40)+$0.40($0.17)$0.21 million$0.21 million    
5/16/2021Q1 2021($3.40)($5.00)($1.60)($0.25)$0.68 million$0.69 million  
3/29/2021Q4 2020($4.40)($12.00)($7.60)($0.60)$0.54 million$0.20 million  












INVO Bioscience Earnings - Frequently Asked Questions

When is INVO Bioscience's earnings date?

INVO Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 15th, 2024 based off last year's report dates. Learn more on INVO's earnings history.

How much revenue does INVO Bioscience generate each year?

INVO Bioscience (NASDAQ:INVO) has a recorded annual revenue of $820,000.00.

How much profit does INVO Bioscience generate each year?

INVO Bioscience (NASDAQ:INVO) has a recorded net income of -$10.89 million. INVO has generated -$12.36 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:INVO) was last updated on 3/1/2024 by MarketBeat.com Staff